mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.06 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.06 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.06 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.07 |